Finance

Lists
PRTC:LON
Puretech Health PLC
GBXĀ 119.40
-1.97%
(-2.40) 1D
Nov 6, 4:35:29ā€ÆPM UTC  ·   GBX
All symbols
SymbolPriceChange% Change
Generating top insights for PRTC...
Open
GBXĀ 120.00
High
GBXĀ 120.20
Low
GBXĀ 117.00
Mkt. cap
379.67M
Avg. vol.
554.78K
Volume
402.15K
P/E ratio
1,474.07
52-wk high
GBXĀ 143.60
52-wk low
GBXĀ 106.60
EPS
GBXĀ 0.00
Shares outstanding
245.18M
No. of employees
90
Open
GBXĀ 120.00
High
GBXĀ 120.20
Low
GBXĀ 117.00
Mkt. cap
379.67M
Avg. vol.
554.78K
Volume
402.15K
P/E ratio
1,474.07
52-wk high
GBXĀ 143.60
52-wk low
GBXĀ 106.60
EPS
GBXĀ 0.00
Shares outstanding
245.18M
No. of employees
90
News stories
From web sources and news partners
Profile
PureTech Health is an American biotechnology company which develops medicines to combat serious diseases. It is listed on the London Stock Exchange. Wikipedia
About Puretech Health PLC
CEORobert Lyne
Employees90
Founded2005
HeadquartersBoston, Massachusetts, United States
SectorHealth Care
IndustryBiotechnology
Websitepuretechhealth.com
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
1.40M
1.40M
1.78M
1.78M
Cost of goods sold
15.78M
15.78M
16.94M
16.94M
Cost of revenue
15.78M
15.78M
16.94M
16.94M
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
10.87M
10.87M
10.99M
10.99M
Operating expense
10.87M
10.87M
10.99M
10.99M
Total operating expenses
26.64M
26.64M
27.93M
27.93M
Operating income
-25.24M
-25.24M
-26.15M
-26.15M
Other non operating income
207.00K
207.00K
338.00K
338.00K
EBT including unusual items
-33.53M
-33.53M
36.41M
36.41M
EBT excluding unusual items
-51.43M
-51.43M
-26.29M
-26.29M
Income tax expense
-882.50K
-882.50K
3.04M
3.04M
Effective tax rate
2.63%
2.63%
8.35%
8.35%
Other operating expenses
-
-
-
-
Net income
-32.57M
-32.57M
33.62M
33.62M
Net profit margin
-2,319.59%
-2,319.59%
1,890.58%
1,890.58%
Earnings per share
-
-
-
-
Interest and investment income
2.99M
2.99M
2.17M
2.17M
Interest expense
-22.42M
-22.42M
-12.42M
-12.42M
Net interest expenses
-19.43M
-19.43M
-10.26M
-10.26M
Depreciation and amortization charges
-
-
-
-
EBITDA
-24.70M
-24.84M
-25.33M
-25.33M
Gain or loss from assets sale
500.00
500.00
-7.00K
-7.00K
Upcoming events
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps